| Literature DB >> 35414798 |
Yi Zhu1, Hai Cheng2, Rui Min1, Tong Wu1.
Abstract
The aim of this work was to explore the effect of the nomogram mathematical model on the treatment of cerebral infarction complicated with nonvalvular atrial fibrillation (NVAF) and viral infection. The data were scanned by a circular trajectory fan beam isometric scanning mode system (scanning system), and the speckle noise of computed tomography (CT) images was smoothed by Lee filtering. 52 patients with postoperative recurrent viral infection (RVI group) and 248 patients without postoperative recurrent viral infection (NRVI group) were selected for retrospective analysis. The mathematical model curve was then analyzed through calibration plots and decision curves to predict the accuracy of the mathematical model. The results showed that the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and accuracy based on the training set were 0.7868, 0.7634, 0.6982, and 0.7146, respectively. The AUC, sensitivity, specificity, and accuracy based on the validation set were 0.7623, 0.7734, 0.6882, and 0.6948, respectively. There was no significant difference in the AUC between the two groups (P > 0.05), indicating that the nomogram mathematical prediction model had high repeatability. In conclusion, CT images based on the nomogram mathematical prediction model had good predictive ability in the treatment of cerebral infarction complicated with NVAF.Entities:
Mesh:
Year: 2022 PMID: 35414798 PMCID: PMC8977295 DOI: 10.1155/2022/3950641
Source DB: PubMed Journal: Contrast Media Mol Imaging ISSN: 1555-4309 Impact factor: 3.161
Figure 1The screening process of research objects.
Calculation methods of CHADS2 score and derivative scores.
| CHADS2 | CHA2DS2 | R2CHADS2 | |||
|---|---|---|---|---|---|
| Risk factors | Score (s) | Risk factors | Score (s) | Risk factors | Score (s) |
| CHF | 1 | CHF | 1 | CHF | 1 |
| Diabetes | 1 | Diabetes | 1 | Diabetes | 1 |
| Age ≥75 years | 1 | Age ≥75 years | 2 | Age ≥75 years | 1 |
| Hypertension | 1 | Hypertension | 1 | Hypertension | 1 |
| Stroke/transient ischemic attack | 2 | Stroke/transient ischemic attack | 2 | Stroke/transient ischemic attack | 2 |
| 65 < age ≤ 75 | 1 | Estimated glomerular filtration rate (GFR) ≤ 60 | 2 | ||
| Vascular disease | 1 | ||||
| Female | 1 | ||||
| Total scores | 6 | Total scores | 9 | Total scores | 8 |
Note: CHA2DS2 refers to CHF, hypertension, age ≥75 years [doubled], diabetes, stroke/transient ischemic attack. R2CHADS2 refers to renal dysfunction, CHF, hypertension, age ≥75 years, diabetes, stroke/transient ischemic attack.
Figure 2The schematic diagram of Beer's law.
Figure 3The schematic diagram of circular track fan beam isometric scanning mode.
Figure 4Preprocess flow of CT image.
Basic data of research objects.
| Factor | mRS ≤2 | mRS >3 | X2/ |
|
|---|---|---|---|---|
| Score of stroke at admission | 9.00 (4.00, 11.00) | 10.00 (7.00, 14.00) | −4.138 | ≤0.001 |
| Age | 68.72 ± 5.62 | 70.35 ± 5.81 | −1.321 | 0.136 |
| Coagulation function | 1.07 ± 0.05 | 1.06 ± 0.03 | −1.876 | 0.043 |
| Gender | 54 | 43 | 0.028 | 0.812 |
| Cerebral infarction area | 49 | 20 | 4.861 | 0.011 |
| History of alcohol abuse | 60 | 51 | 1.621 | 0.172 |
| CHF | 72 | 50 | 0.065 | 0.658 |
Comparison of clinical characteristics between patients in the RVI group and NRVI group after atrial fibrillation.
| Variable | Patients in the RVI group ( | Patients in the NRVI group ( |
|
|---|---|---|---|
| Diabetes (%) | 11 (21.15) | 48 (19.35) | 0.287 |
| Hyperlipidemia (%) | 7 (13.46) | 26 (10.48) | 0.072 |
| Diuretics (%) | 6 (11.54) | 21 (8.47) | 0.154 |
| Beta blockers (%) | 7 (13.46) | 27 (10.89) | 0.132 |
| Lipid-lowering drugs (%) | 23 (44.23) | 68 (27.42) | 0.045 |
| COPD (%) | 2 (0.038) | 13 (0.052) | 0.218 |
| Antiplatelet drugs (%) | 19 (36.54) | 72 (0.29) | 0.467 |
| Active atrial electrode (%) | 28 (53.85) | 145 (58.47) | 0.523 |
| Active ventricular electrode (%) | 38 (73.08) | 208 (83.87) | 0.765 |
| Cardiac ultrasound | |||
| LVEF (%) | 5 (9.62) | 8 (3.23) | 0.231 |
| LAD (%) | 21 (40.38) | 61 (24.90) | 0.056 |
| Laboratory indicators | |||
| BUN (mg/L) | 5.26 (±1.86) | 5.89 (±2.12) | 0.248 |
| C-reactive protein (mg/L) | 1.5 (0.5–3.9) | 1.5 (0.5–4.2) | 0.543 |
| Follow-up parameters | |||
| AP-VP ≥ 50 (%) | 11 (21.15) | 19 (7.66) | 0.012 |
| AP ≥ 50 (%) | 28 (53.84) | 82 (33.06) | 0.038 |
| VP ≥ 50 (%) | 29 (55.77) | 89 (35.89) | 0.069 |
Note: COPD refers to chronic obstructive pulmonary disease; LEVF refers to left ventricular ejection fraction; BUN represents blood urea nitrogen; VP refers to the score of sepsis-related organ failure assessment; and AP is the short form of adapted physical activity and cardiac coherence in hematologic patients (APACCHE).
Figure 5Nomogram figure of a patient with cerebral infarction combined with NVAF.
Figure 6The ROC curve and model calibration curve of the prediction model on the training set and validation set. indicates the difference was statistically obvious (P < 0.05).
Figure 7CT images of cerebral infarction.
Figure 8Clinical decision curve of the predictive model of atrial fibrillation after viral infection.